David B Abrams
David Abrams
Scroll
Professor of Social and Behavioral Sciences
-
Professional overview
-
Dr. David Abrams' career focuses on systems and social learning frameworks to inform population health enhancement. He has experience in testing theory, research design, measuring mechanisms of behavior change and outcome, and evaluating clinical trials (behavioral and pharmacological). His interests span topics from basic bio-behavioral mechanisms and clinical treatments to policy across risk factors and behaviors (e.g. tobacco/nicotine; alcohol, obesity, co-morbidity of medical and mental health), disease states (cancer; cardiovascular; HIV-AIDS), levels (biological, individual, organizational, worksite, community, global, and internet based), populations and disparities. His interests converge in the domain of implementation science to cost-efficiently inform evidence-based public health practice and policymaking.
Through transdisciplinary and translational research strategies, Dr. Abrams provides scientific leadership in tobacco control. His current focus is in strengthening global and United States tobacco and nicotine management strategies. Deaths of 1 billion smokers are estimated by 2100 caused overwhelmingly by use of combustible (smoked) tobacco products, not nicotine. Harm minimization is a key overarching systems strategy to speed the net public health benefit of emergent disruptive technologies for cleaner nicotine delivery. The goal is more rapid elimination of preventable deaths, disease burdens, and the widening gap in health disparities driven disproportionately by disparities in smoking.
Dr. Abrams was a professor and founding director of the Centers for Behavioral and Preventive Medicine at Brown University Medical School. He then directed the Office of Behavioral and Social Sciences Research at the National Institutes of Health (NIH). Until 2017, he was Professor of Health Behavior and Society at Johns Hopkins Bloomberg School of Public Health and the founding Executive Director of the Schroeder National Institute of Tobacco Research and Policy Studies at Truth Initiative (formerly the American Legacy Foundation).
Dr. Abrams has published over 250 peer reviewed scholarly articles and been a Principal Investigator on numerous NIH grants. He is lead author of The Tobacco Dependence Treatment Handbook: A Guide to Best Practices. He has served on expert panels at NIH and National Academies of Sciences, Engineering and Medicine on Obesity, Alcohol Misuse and Ending the Tobacco Problem: A Blueprint for the Nation. He has also served on the Board of Scientific Advisors of the National Cancer Institute (NIH-NCI) and was President of the Society of Behavioral Medicine.
For a complete list of Dr. Abrams' published work, click here.
-
Education
-
BSc (Hons), Psychology and Computer Science, University of the Witwatersrand, Johannesburg, South AfricaMS, Clinical Psychology, Rutgers University, New Brunswick, NJPhD, Clinical Psychology, Rutgers University, New Brunswick, NJPostdoctoral Fellow, Brown Medical School, Providence, RI
-
Honors and awards
-
Research Laureate Award, American Academy of Health Behavior (2014)Joseph W. Cullen Memorial Award for Tobacco Research, American Society for Preventive Oncology (2008)Distinguished Alumni Award: Rutgers University, The Graduate School, New Brunswick, NJ (2007)The Musiker-Miranda Distinguished Service Award, American Psychological Association (2006)Distinguished Service Award, Society of Behavioral Medicine (2006)Outstanding Research Mentor Award, Society of Behavioral Medicine (2006)Book of the Year Award: Tobacco Dependence Treatment Handbook. American Journal of Nursing (2005)Distinguished Scientist Award, Society of Behavioral Medicine (1998)
-
Areas of research and study
-
Behavioral ScienceChronic DiseasesEvaluationsImplementation and Impact of Public Health RegulationsImplementation sciencePopulation HealthPublic Health PedagogyPublic Health SystemsResearch DesignSystems IntegrationSystems InterventionsTobacco ControlTranslational science
-
Publications
Publications
Cognitive-behavioral coping skills program for alcoholics : Monograph No. 3. National Institute of Alcohol Abuse and Alcoholism
AbstractAbrams, D., Kadden, R., Carroll, K., Donovan, D., Abrams, D. S., & et, al. (n.d.).Publication year
1993Abstract~Cognitive-behavioral mediators of changing multiple behaviors : Smoking and a sedentary lifestyle
AbstractAbrams, D., King, T. K., Marcus, B. H., Pinto, B. M., Emmons, K. M., & Abrams, D. B. (n.d.).Publication year
1996Journal title
Preventive MedicineVolume
25Issue
6Page(s)
684-691AbstractBackground. A significant percentage of the U.S. population has multiple poor health behaviors. Understanding the relationship among these behavioral risk factors is important for designing effective multiple risk factor interventions. While there is some evidence suggesting that participation in physical exercise may have a positive impact on smoking cessation, there is much to be learned about the relationships between cognitive-behavioral (self-efficacy, decisional-balance) and motivational mechanisms (stage of change) which have been shown to mediate changes in both exercise and smoking behavior. Methods. The sample comprised 332 smokers employed at two workplaces-a government agency and a medical center-recruited as part of a larger worksite health promotion project and who completed questionnaires on their smoking and exercise behaviors. Results. The results revealed significant relationships between smoking variables and exercise variables. Smokers who rated as important the positive benefits of smoking also rated as important the costs associated with increased physical activity. Similarly, the negative consequences of smoking were significantly associated with the positive benefits of physical activity. Self-efficacy for one behavior was significantly associated with self-efficacy for the other. Significant differences by exercise and smoking stage of change were found on the cross- behavior sets of variables (self-efficacy, pros, cons). Smokers who were contemplating a more active lifestyle reported the negative consequences of smoking to be significantly more important to them than smokers who were not considering adoption of a more active lifestyle. Smokers who were exercising regularly reported significantly more confidence in their ability to refrain from smoking than smokers not exercising regularly. Finally, smokers preparing for quitting reported less confidence in their ability to exercise than smokers who had already taken action to change their smoking behavior. Conclusions. The cognitive mechanisms associated with changes in smoking behavior are related to the cognitive variables which have been shown to predict changes in exercise behavior. Significant relationships in mediating mechanisms including decisional balance and self-efficacy between smoking and exercise provide preliminary information on how change in one risk behavior may relate to change in another. These associations have implications for future intervention research and for methods research on multiple risk factor interactions.Cognitive-behavioral treatment for depression in smoking cessation
AbstractAbrams, D., Brown, R. A., Kahler, C. W., Niaura, R. S., Abrams, D. B., Sales, S. D., Ramsey, S. E., Goldstein, M. G., Burgess, E. S., & Miller, I. W. (n.d.).Publication year
2001Journal title
Journal of consulting and clinical psychologyVolume
69Issue
3Page(s)
471-480AbstractCigarette smokers with past major depressive disorder (MDD) received 8 group sessions of standard, cognitive-behavioral smoking cessation treatment (ST; n = 93) or standard, cognitive-behavioral smoking cessation treatment plus cognitive-behavioral treatment for depression (CBT-D; n = 86). Although abstinence rates were high in both conditions (ST, 24.7%; CBT-D, 32.5%, at 1 year) for these nonpharmacological treatments, no main effect of treatment was found. However, secondary analyses revealed significant interactions between treatment condition and both recurrent depression history and heavy smoking (≥25 cigarettes a day) at baseline. Smokers with recurrent MDD and heavy smokers who received CBT-D were significantly more likely to be abstinent than those receiving ST (odds ratios = 2.3 and 2.6, respectively). Results suggest that CBT-D provides specific benefits for some, but not all, smokers with a history of MDD.Commentary on stages of change and decisional balance for twelve problem behaviors.
AbstractAbrams, D., Abrams, D. S., & Clark, M. (n.d.).Publication year
1992Journal title
Diabetes SpectrumVolume
6Issue
1Page(s)
38-40Abstract~Commentary on strong and weak principles for progressing from precontemplation into action based on 12 problem behaviors
AbstractAbrams, D., Clark, M., & Abrams, D. S. (n.d.).Publication year
1992Journal title
Diabetes SpectrumVolume
6Issue
1Page(s)
41-42Abstract~Commentary on Wagener etal. (2012) : Laissez-faire regulation: Turning back the clock on the Food and Drug Administration and public health
AbstractAbrams, D., Cobb, N. K., & Abrams, D. B. (n.d.).Publication year
2012Journal title
AddictionVolume
107Issue
9Page(s)
1552-1554Abstract~Comments on "Challenges to Improving the Impact of Worksite Cancer Prevention Programs" : Paradigm Lost?
AbstractAbrams, D., Winett, R. A., Linnan, L., Klar, N., Emmons, K., LaForge, R., Fava, J., & Abrams, D. S. (n.d.).Publication year
2003Journal title
Annals of Behavioral MedicineVolume
26Issue
3Abstract~Communication skills training, communication skills training with family and cognitive behavioral mood management training for alcoholics
AbstractAbrams, D., Monti, P. M., Abrams, D. B., Binkoff, J. A., Zwick, W. R., Liepman, M. R., Nirenberg, T. D., & Rohsenow, D. J. (n.d.).Publication year
1990Journal title
Journal of Studies on AlcoholVolume
51Issue
3Page(s)
263-270AbstractTo evaluate three promising social learning approaches to the treatment of alcholism, 69 male alcoholics in standard inpatient treatment participated in either a communication skills training group (CST), a communication skills training group with family participation (CSTF) or a cognitive behavioral mood management training group (CBMMT). Alcoholics who received CST or CSTF drank significantly less alcohol per drinking day during 6-month follow-up than those in CBMMT. The groups did not differ in abstinence rates or latency to relapse. All groups improved in skill and anxiety on the extensive battery of process measures, including role-play tests of general and alcohol-specific coping skills, but those in CST improved most in skill in alcohol-specific high-risk role plays and in ability to relax after the role plays. Alcoholics' skill, specific role plays were highly correlated with treatment outcome, demonstrating the importance of including comprehensive process measures in treatment outcome research. Implications for patient-treatment matching and future research are discussed.Community-wide heart disease prevention
AbstractAbrams, D., Lassater, T., Elder, J., & Abrams, D. S. (n.d.).Publication year
1981Journal title
Behavioral Medicine UpdateVolume
5Page(s)
251-264Abstract~Comorbidity, smoking behavior and treatment outcome
AbstractAbrams, D., Keuthen, N. J., Niaura, R. S., Borrelli, B., Goldstein, M., DePue, J., Murphy, C., Gastfriend, D., Reiter, S. R., & Abrams, D. S. (n.d.).Publication year
2000Journal title
Psychotherapy and PsychosomaticsVolume
69Issue
5Page(s)
244-250AbstractBackground: A sizeable sector of the population continues to smoke cigarettes despite our efforts to prevent and treat this addiction. We explored the relationships between lifetime comorbidity, psychiatric symptomatology, smoking behavior and treatment outcome to better understand vulnerability to smoking and treatment response. Methods: One hundred and twenty smokers at two sites were enrolled in a multicenter, double-blind, randomized, 10-week smoking cessation trial with fluoxetine and behavioral treatment. The Structured Clinical Interview for DSM-III-R and Hamilton Depression Rating Scale were administered prior to treatment initiation. Self-report measures were used to assess psychiatric symptoms throughout treatment and during a 6-month follow-up period. Results: Overall 62.3% of our sample were diagnosed with a lifetime mood, anxiety or substance use disorder despite stringent study exclusion criteria. Lifetime comorbidity was shown to be related to higher smoking rates and nicotine dependence, depressed mood and greater self-report of anxiety and stress. Lifetime comorbidity, however, alone or in combination with treatment condition, failed to predict treatment outcome (at posttreatment or follow-up). Baseline depression scores (Beck Depression Inventory, BDI) were related to treatment outcome only for smokers without a positive history of any psychiatric disorder or depression, with lower BDI scores more frequent in those who were abstinent. Conclusions: High prevalence rates of lifetime psychiatric illness and substance use disorders are reported for chronic smokers. Subsyndromal psychiatric symptoms may play a role in smoking behavior in combination with diagnosable disorders. Clinicians need to carefully assess both psychiatric diagnoses and symptoms in chronic smokers to optimize patient-treatment matching. Copyright (C) 2000 S. Karger AG, Basel.Comparative effectiveness of three types of spouse involvement in outpatient behavioral alcoholism treatment
AbstractAbrams, D., McCrady, B. S., Noel, N. E., Abrams, D. B., Stout, R. L., Nelson, H. F., & Hay, W. M. (n.d.).Publication year
1986Journal title
Journal of Studies on AlcoholVolume
47Issue
6Page(s)
459-467AbstractTreatment was provided to 53 alcoholics and their spouses in one of three outpatient behavioral treatment conditions: minimal spouse involvement (MSI) (N = 21), alcohol-focused spouse involvement (AFSI) (N = 13) or alcohol-focused spouse involvement plus behavioral marital therapy (ABMT) (N = 19). Subjects were followed for 6 months after treatment. All subjects markedly decreased their drinking and reported increased life satisfaction. ABMT subjects were more compliant than AFSI subjects with conjoint homework assignments, decreased their drinking more quickly during treatment, relapsed more slowly after treatment and maintained marital satisfaction better. ABMT subjects were more likely than MSI subjects to stay in treatment and maintained their marital satisfaction better after treatment. Clinical and theoretical significance of the findings are discussed.Comparison of ecological momentary assessment versus direct measurement of E-cigarette use with a bluetooth-enabled E-cigarette:a pilot study
AbstractAbrams, D., Pearson, J. L., Elmasry, H., Das, B., Smiley, S. L., Rubin, L. F., DeAtley, T., Harvey, E., Zhou, Y., Niaura, R. S., & Abrams, D. B. (n.d.).Publication year
2017Journal title
JMIR Research ProtocolsVolume
6Issue
5AbstractBackground: Assessing the frequency and intensity of e-cigarette use presents special challenges beyond those posed by cigarette use. Accurate measurement of e-cigarette consumption, puff duration, and the stability of these measures over time will be informative for estimating the behavioral and health effects of e-cigarette use. Objective: The purpose of this pilot study was to compare the accuracy of self-reported e-cigarette puff counts collected via ecological momentary assessment (EMA) to objective puff count data collected by a Bluetooth-enabled e-cigarette device and to examine the feasibility and acceptability of using a second-generation e-cigarette among adult smokers. Methods: A total of 5 adult smokers were enrolled in a longitudinal parent study assessing how e-cigarette use affects cigarette use among e-cigarette-naïve smokers. Using a text message-based EMA system, participants reported e-cigarette puffs for 2 weeks. Participants were also given a Bluetooth-enabled e-cigarette (Smokio) that passively collected puff counts and puff duration. Comparisons between mean reports of Smokio (device-report) and EMA (self-report) use were evaluated using paired t tests. Correlation and agreement between device- and self-reports were evaluated using Pearson correlation and the concordance correlation coefficient (CCC), respectively. A linear mixed effect model was used to determine the fixed effect of timing and Smokio-reported daily puffs on report accuracy. We examined the relationship between time of day and reporting accuracy using Tukey's test for multiple pairwise comparisons. Results: A total of 5 African American participants, 4 men and 1 woman, who ranged in age from 24 to 59 years completed the study, resulting in 5180 observations (device-report) of e-cigarette use. At baseline, participants reported smoking for 5 to 25 years and consumed a mean of 7 to 13 cigarettes per day (CPD); 4 smoked within 30 minutes of waking. At the 30-day follow-up, CPD range decreased to 1 to 3 cigarettes; 4 participants reported past 7-day e-cigarette use, and 1 participant reported no cigarette smoking in the past 7 days. Over 2 weeks of e-cigarette use, participants took an average of 1074 e-cigarette (SD 779.0) puffs per person as captured by the device reports. Each participant took a mean of 75.0 (SD 58.8) puffs per day, with each puff lasting an average of 3.6 (SD 2.4) seconds. Device reports captured an average of 33.3 (SD 47.8) more puffs per person per day than the self-reported e-cigarette puffs. In 87% of days, participants underestimated the number of puffs they had taken on the Smokio. There was significant moderate correlation (r=.47, PCompensation predicts smoking cessation failure
AbstractAbrams, D., Niaura, R. S., Pearson, J. L., & Abrams, D. B. (n.d.).Publication year
2013Journal title
PsychopharmacologyVolume
230Issue
2Page(s)
261-266AbstractRationale: Compensation is a potential result of decreasing the available nicotine and tar dose in cigarettes. There is little published data linking compensation with cessation. Objectives: We sought to examine whether compensation in response to restricted cigarette yield is associated with difficulty quitting smoking. Methods: Questionnaires and blood samples were collected from 174 smokers interested in quitting smoking as part of a larger smoking cessation study. Participants were instructed to use a filter designed to remove 50 % of tar and nicotine from the cigarette but otherwise smoke normally. Participants returned after 3 days of using the filter for follow-up data collection. Results: Nicotine levels and cigarettes per day decreased after use of the filter. Baseline nicotine and change in nicotine pre/post filter use, but not cigarettes per day or change in cigarettes per day were associated with smoking abstinence at 30 days. Conclusions: Smokers who demonstrate sensitivity to the biological or behavioral consequences of decreased nicotine content in tobacco smoke have greater difficulty quitting. These findings suggest the need for personalized cessation treatment linked to behavioral compensation.Complying with the framework convention for tobacco control : An application of the Abridged SimSmoke model to Israel
AbstractAbrams, D., Levy, D. N., Abrams, D. B., Levy, J., & Rosen, L. (n.d.).Publication year
2016Journal title
Israel Journal of Health Policy ResearchVolume
5Issue
1AbstractBackground: The World Health Organization Framework Convention for Tobacco Control (FCTC) established the MPOWER policy package to provide practical country-level guidance on implementing effective policies to reduce smoking rates. The Abridged SimSmoke tobacco control policy simulation model is applied to Israel to estimate the effects on reducing smoking-attributable mortality resulting from full implementation of MPOWER policies. Methods: Smoking prevalence from the 2014 Israel National Health Interview Survey 3 and population data from the Israel Central Bureau of Statistics were used to calculate the number of current smokers. The status of current Israeli policy was determined using information from MPOWER 2015 and from local sources. Based on existing knowledge that between 50 % and 65 % of smokers will die prematurely from smoking, the model is used to determine mortality reductions among current smokers from full implementation of MPOWER policies. Results: We estimate that between 550 and 710 thousand smokers of the current 1.1 million Israeli smokers will prematurely die due to smoking. Within 40 years, complete implementation of MPOWER policies is projected to reduce smoking prevalence among current smokers by 34 % and avert between 188 and 245 thousand deaths among current smokers. Taxes, smoke-free air laws, marketing restrictions and media campaigns each reduce smoking by about 5 % within 5 years. Improved cessation treatment and health warnings each have smaller effects in the next five years, but their effects grow rapidly over time. Conclusions: Israel Abridged SimSmoke shows that complete implementation of the MPOWER strategies has the potential to substantially reduce smoking prevalence, and avert premature deaths due to smoking. Additional benefits are also expected from reduced morbidity, reduced initiation among nonsmokers, and reduction in exposure of nonsmokers to tobacco smoke.Comprehensive Smoking Cessation: Systems Integration to Save Lives and Money
AbstractAbrams, D., & Abrams, D. S. (n.d.).Publication year
2007Page(s)
A1-A50Abstract~Computational models used to assess US tobacco control policies
AbstractAbrams, D., Feirman, S. P., Glasser, A. M., Rose, S., Niaura, R., Abrams, D. B., Teplitskaya, L., & Villanti, A. C. (n.d.).Publication year
2017Journal title
Nicotine and Tobacco ResearchVolume
19Issue
11Page(s)
1257-1267AbstractIntroduction: Simulation models can be used to evaluate existing and potential tobacco control interventions, including policies. The purpose of this systematic review was to synthesize evidence from computational models used to project population-level effects of tobacco control interventions. We provide recommendations to strengthen simulation models that evaluate tobacco control interventions. Methods: Studies were eligible for review if they employed a computational model to predict the expected effects of a non-clinical US-based tobacco control intervention. We searched five electronic databases on July 1, 2013 with no date restrictions and synthesized studies qualitatively. Results: Six primary non-clinical intervention types were examined across the 40 studies: taxation, youth prevention, smoke-free policies, mass media campaigns, marketing/advertising restrictions, and product regulation. Simulation models demonstrated the independent and combined effects of these interventions on decreasing projected future smoking prevalence. Taxation effects were the most robust, as studies examining other interventions exhibited substantial heterogeneity with regard to the outcomes and specific policies examined across models. Conclusions: Models should project the impact of interventions on overall tobacco use, including nicotine delivery product use, to estimate preventable health and cost-saving outcomes. Model validation, transparency, more sophisticated models, and modeling policy interactions are also needed to inform policymakers to make decisions that will minimize harm and maximize health. Implications: In this systematic review, evidence from multiple studies demonstrated the independent effect of taxation on decreasing future smoking prevalence, and models for other tobacco control interventions showed that these strategies are expected to decrease smoking, benefit population health, and are reasonable to implement from a cost perspective. Our recommendations aim to help policymakers and researchers minimize harm and maximize overall populationlevel health benefits by considering the real-world context in which tobacco control interventions are implemented.Conceptual models to integrate individual and public health interventions: The example of the workplace
AbstractAbrams, D., & Abrams, D. S. (n.d.). (M. Henderson, Ed.).Publication year
1992Abstract~Contrasting Short- and Long-term Effects of Weight Loss on Lipoprotein Levels
AbstractAbrams, D., Follick, M. J., Abrams, D. B., Smith, T. W., Henderson, L. O., & Herbert, P. N. (n.d.).Publication year
1984Journal title
Archives of Internal MedicineVolume
144Issue
8Page(s)
1571-1574AbstractThe short- and long-term effects of weight loss on high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol levels were examined In 42 women who completed a 14-session behavioral weight-loss program. Lipid values were determined from samples taken before treatment, after treatment, and at six-month follow-up. There were significant changes in plasma lipid levels, but the short- and long-term effects differed. Both total and LDL cholesterol levels decreased during treatment and remained lower at follow-up. However, HDL cholesterol level and the HDL/LDL ratio did not change during treatment but increased significantly above pretreatment levels at follow-up. Furthermore, long-term changes In lipoprotein levels were significantly correlated with changes in the body-mass index even after correction for Initial values. These results show that weight loss can, in the long term, have a potentially beneficial impact on lipoprotein levels in women.Contrasting short- and long-term effects of weight loss on lipoprotein levels
AbstractAbrams, D., Follick, M. J., Abrams, D. S., Smith, T. W., Henderson, L. O., & Herbert, P. N. (n.d.).Publication year
1984Journal title
Archives of Internal MedicineVolume
144Issue
8Page(s)
1571-1574AbstractThe short- and long-term effects of weight loss on high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol levels were examined in 42 women who completed a 14-session behavioral weight-loss program. Lipid values were determined from samples taken before treatment, after treatment, and at six-month follow-up. There were significant changes in plasma lipid levels, but the short- and long-term effects differed. Both total and LDL cholesterol levels decreased during treatment and remained lower at follow-up. However, HDL cholesterol level and the HDL/LDL ratio did not change during treatment but increased significantly above pretreatment levels at follow-up. Furthermore, long-term changes in lipoprotein levels were significantly correlated with changes in the body-mass index even after correction for initial values. These results show that weight loss can, in the long term, have a potentially beneficial impact on lipoprotein levels in women.Coping and social skills training
AbstractAbrams, D., Monti, P., Rohsenow, D., Colby, S., & Abrams, D. S. (n.d.). (R. Hester & W. Miller, Eds.; 2nd ed.).Publication year
1995Abstract~Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment
AbstractAbrams, D., Martin, R. A., Rohsenow, D. J., MacKinnon, S. V., Abrams, D. B., & Monti, P. M. (n.d.).Publication year
2006Journal title
Drug and alcohol dependenceVolume
83Issue
1Page(s)
73-78AbstractSubstance use and smoking co-occur at high rates and substance abusers smoke more and have greater difficulty quitting smoking compared to the general population. Methods of increasing smoking cessation among alcoholics are needed to improve their health. This study investigated predictors of motivation to quit smoking among patients early in residential treatment for substance abuse. The 198 alcohol dependent patients were participating is a larger smoking study at an inner-city residential substance abuse treatment program. Motivation was measured by the Contemplation Ladder. A hierarchical multiple regression was conducted to assess whether perceived barriers to smoking cessation and self-efficacy about quitting were associated with motivation to quit smoking independent of the influence of degree of tobacco involvement, substance use, and comorbid depressive symptoms. Motivation was higher with longer previous smoking abstinence, fewer barriers to quitting, and greater self-efficacy but was not influenced by smoking rate, dependence, or gender. While the combination of alcohol and drug use, alcohol and drug problem severity, and depressive symptoms predicted motivation, no one of these variables was significant. Since barriers to change and self-efficacy are potentially modifiable in treatment, these could be salient targets for intervention efforts. This could be integrated into treatment by assessing barriers and providing corrective information about consequences and methods of overcoming barriers and by providing coping skills to increase confidence in one's ability to quit smoking.Correlates of transitions in tobacco product use by u.S. adult tobacco users between 2013–2014 and 2014–2015 : Findings from the path study wave 1 and wave 2
AbstractAbrams, D., Kasza, K. A., Coleman, B., Sharma, E., Conway, K. P., Cummings, K. M., Goniewicz, M. L., Niaura, R. S., Lambert, E. Y., Schneller, L. M., Feirman, S. P., Donaldson, E. A., Cheng, Y. C., Murphy, I., Pearson, J. L., Trinidad, D. R., Bansal-Travers, M., Elton-Marshall, T., Gundersen, D. A., … Hyland, A. J. (n.d.).Publication year
2018Journal title
International journal of environmental research and public healthVolume
15Issue
11AbstractMore than half of adult tobacco users in the United States (U.S.) transitioned in tobacco product use between 2013–2014 and 2014–2015. We examine how characteristics of adult tobacco users in the U.S. relate to transitions in tobacco product use. Population Assessment of Tobacco and Health (PATH) Study data were analyzed from 12,862 adult current tobacco users who participated in Wave 1 (W1, 2013–2014) and Wave 2 (W2, 2014–2015). Three types of transitions were examined—(1) adding tobacco product(s); (2) switching to non-cigarette tobacco product(s); and (3) discontinuing all tobacco use—among those currently using: (1) any tobacco product; (2) cigarettes only (i.e., exclusive cigarette); and (3) cigarettes plus another tobacco product(s) (i.e., poly-cigarette). Multinomial logistic regression analyses determined relative risk of type of transition versus no transition as a function of demographic and tobacco use characteristics. Transitions in tobacco product use among adult tobacco users were common overall, but varied among different demographic groups, including by age, sex, sexual orientation, race/ethnicity, educational attainment, and poverty level. Further, cigarette smokers with higher dependence scores were more likely to add product(s) and less likely to discontinue tobacco use compared to those with low dependence scores. That high nicotine dependence is a barrier to discontinuing tobacco use adds evidence to support policy to lower nicotine content of cigarettes and to evaluate new products for their potential to reduce cigarette use.Corrigendum to “Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013–2014)” [Addict. Behav. 91 (2019) 51–60, (S0306460318313364), (10.1016/j.addbeh.2018.11.027)]
AbstractAbrams, D., Sawdey, M. D., Day, H. R., Coleman, B., Gardner, L. D., Johnson, S. E., Limpert, J., Hammad, H. T., Goniewicz, M. L., Abrams, D. S., Stanton, C. A., Pearson, J. L., Kaufman, A. R., Kimmel, H. L., Delnevo, C. D., Compton, W. M., Bansal-Travers, M., Niaura, R. S., Hyland, A., & Ambrose, B. K. (n.d.).Publication year
2025Journal title
Addictive BehaviorsAbstractIt has come to our attention that important conflict of interests were not disclosed by the authors in the original publication of the article “Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013–2014)” in “Addictive Behaviors”. In the interest of transparency and accuracy, this corrigendum is issued to address and rectify this oversight. Dr. Abrams and Niaura declare that between 2015 and 2020, they frequently communicated with Juul Labs personnel and attended several meetings with JUUL personnel as invited guests, at which they presented information pertaining to their scientific research. They did not receive any honoraria, reimbursements or compensation for attending these meetings, except for hospitality in the form of meals. Between 2015 and 2020 Dr. Abrams and Niaura reported grants from a Westat subcontract and other grants from the NIH (NIDA-NCI-FDA) paid to their employers; receiving salary from the Steven Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, and New York University School of Global Public Health. Dr. Niaura was a scientific consultant on a grant which was awarded to Johns Hopkins University, from which they received consulting payments.Cost-effectiveness of internet and telephone treatment for smoking cessation : An economic evaluation of the iQUITT study
AbstractAbrams, D., Graham, A. L., Chang, Y., Fang, Y., Cobb, N. K., Tinkelman, D. S., Niaura, R. S., Abrams, D. B., & Mandelblatt, J. S. (n.d.).Publication year
2013Journal title
Tobacco controlVolume
22Issue
6AbstractBackground Internet and telephone treatments for smoking cessation can reach large numbers of smokers. There is little research on their costs and the impact of adherence on costs and effects. Objective To conduct an economic evaluation of The iQUITT Study, a randomised trial comparing Basic Internet, Enhanced Internet and Enhanced Internet plus telephone counselling ('Phone') at 3, 6, 12 and 18 months. Methods We used a payer perspective to evaluate the average and incremental cost per quitter of the three interventions using intention-to-treat analysis of 30-day single-point prevalence and multiple-point prevalence (MPP) abstinence rates. We also examined results based on adherence. Costs included commercial charges for each intervention. Discounting was not included given the short time horizon. Results Basic Internet had the lowest cost per quitter at all time points. In the analysis of incremental costs per additional quitter, Enhanced Internet+Phone was the most cost-effective using both single and MPP abstinence metrics. As adherence increased, the cost per quitter dropped across all arms. Costs per quitter were lowest among participants who used the 'optimal' level of each intervention, with an average cost per quitter at 3 months of US$7 for Basic Internet, US$164 for Enhanced Internet and US$346 for Enhanced Internet +Phone. Conclusions 'Optimal' adherence to internet and combined internet and telephone interventions yields the highest number of quitters at the lowest cost. Cost-effective means of ensuring adherence to such evidence-based programmes could maximise their population-level impact on smoking prevalence.Critical Issues in eHealth Research
AbstractAbrams, D., Atienza, A. A., Hesse, B. W., Baker, T. B., Abrams, D. B., Rimer, B. K., Croyle, R. T., & Volckmann, L. N. (n.d.).Publication year
2007Journal title
American journal of preventive medicineVolume
32Issue
5 SUPPL.Page(s)
S71-74Abstract~